Ovarian cancer

You have access
Impact of Body Mass Index (BMI) on Chemotherapy-associated Toxicity in Ovarian Cancer Patients. A Pooled Analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) Databank on 1,213 Patients
JACEK PRZEMYSLAW GRABOWSKI, ROLF RICHTER, HANNAH RITTMEISTER, RADOSLAV CHEKEROV, HANNAH WOOPEN and JALID SEHOULI

Anticancer Research October 2018, 38 (10) 5853-5858; DOI: https://doi.org/10.21873/anticanres.12927
You have access
Prognostic Value of Serum Creatinine Levels in Patients with Epithelial Ovarian Cancer
JUDITH LAFLEUR, KATRIN HEFLER-FRISCHMUTH, CHRISTOPH GRIMM, RICHARD SCHWAMEIS, LISA GENSTHALER, ELISABETH REISER and LUKAS A. HEFLER

Anticancer Research September 2018, 38 (9) 5127-5130; DOI: https://doi.org/10.21873/anticanres.12834
You have access
Differential Mechanism of Action of 3,4’,7-O-trimethylquercetin in Three Types of Ovarian Cancer Cells
A. H. M. ZUBERI ASHRAF, SYEDA H. AFROZE, KOSEI YAMAUCHI, DAVID C. ZAWIEJA, THOMAS J. KEUHL, LAURA WEISER ERLANDSON and MOHAMMAD N. UDDIN

Anticancer Research September 2018, 38 (9) 5131-5137; DOI: https://doi.org/10.21873/anticanres.12835
You have access
Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes
MARTA MENDIOLA, ANDRÉS REDONDO, VICTORIA HEREDIA-SOTO, JESÚS HERRANZ, ALBERTO BERJÓN, ALICIA HERNÁNDEZ, MARÍA MIGUEL-MARTÍN, ROBERTO CRESPO, JORGE BARRIUSO, PATRICIA CRUZ, LAURA YÉBENES, ALBERTO PELÁEZ-GARCÍA, BEATRIZ CASTELO, ANA RAMÍREZ DE MOLINA, JAIME FELIU and DAVID HARDISSON

Anticancer Research September 2018, 38 (9) 5393-5400; DOI: https://doi.org/10.21873/anticanres.12869
You have access
Preoperative CA-125 Value as a Predictive Factor for Postoperative Outcome in First Relapse of Platinum-sensitive Serous Ovarian Cancer
ASYA PARASHKEVOVA, JALID SEHOULI, ROLF RICHTER, DESISLAVA DIMITROVA, ELENA IOANA BRAICU and MUSTAFA ZELAL MUALLEM

Anticancer Research August 2018, 38 (8) 4865-4870; DOI: https://doi.org/10.21873/anticanres.12799
You have access
Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy
YUKI ABE, HIROHITO KOBAYASHI, YOSHIKA AKIZAWA, KEN ISHITANI, KAZUNORI HASHIMOTO and HIDEO MATSUI

Anticancer Research July 2018, 38 (7) 4327-4331; DOI: https://doi.org/10.21873/anticanres.12732
You have access
Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer
DAISUKE IZUCHI, SATOSHI FUKAGAWA, FUSANORI YOTSUMOTO, KOICHIRO SHIGEKAWA, KENICHI YOSHIKAWA, TOYOFUMI HIRAKAWA, CHIHIRO KIYOSHIMA, NAM SUNG OUK, DAICHI URUSHIYAMA, TAKAHIRO KATSUDA, KOHEI MIYATA, TOMOHIRO ITO, MASAMITSU KURAKAZU, RYOTA ARAKI, AYAKO SANUI, DAISUKE MIYAHARA, MASAHARU MURATA, HIROKO ITO, KYOKO SHIROTA, MASAHIDE KUROKI, SHIN'ICHIRO YASUNAGA and SHINGO MIYAMOTO

Anticancer Research July 2018, 38 (7) 4347-4351; DOI: https://doi.org/10.21873/anticanres.12735
You have access
The Role of PAR1 Autoantibodies in Patients with Primary Epithelial Ovarian Cancer
KATRIN KREIENBRING, ANNIKA FRANZ, ROLF RICHTER, DUSKA DRAGUN, HARALD HEIDECKE, DOMINIK MÜLLER, MONIKA MENTZE, RALF DECHEND, JALID SEHOULI and ELENA IOANA BRAICU

Anticancer Research June 2018, 38 (6) 3619-3625; DOI: https://doi.org/10.21873/anticanres.12636
You have access
Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery
MORGANE PERRIN, ENRICA BENTIVEGNA, CLAIRE BONNEAU, CATHERINE UZAN, ALEXANDRA LEARY, PATRICIA PAUTIER, CATHERINE GENESTIE, PHILIPPE MORICE and SÉBASTIEN GOUY

Anticancer Research April 2018, 38 (4) 2247-2252;
You have access
Polymorphisms of ABCB1, CYP3A4 and CYP3A5 Genes in Ovarian Cancer and Treatment Response in Poles
ŁUCJA FISZER-MALISZEWSKA, ŁUKASZ ŁACZMAŃSKI, ANETA DOLIŃSKA, MARIA JAGAS, EWELINA KOŁODZIEJSKA, MAGDALENA JANKOWSKA and PIOTR KUŚNIERCZYK

Anticancer Research March 2018, 38 (3) 1455-1459;

Main menu

User menu

Search

Ovarian cancer

Pages